ZYEPTI
H. Lundbeck A/S
Trademark Registered: 2021-08-03
Trademark Application Details
NEW APPLICATION - ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79291195 |
| Registration Number | 6436392 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Law Office Assigned | M10 |
| Employee Name | KOVALSKY, LAURA G |
Timeline
| 2020-02-25 | Application Filed |
| 2020-08-14 | Location: TMO LAW OFFICE 110 |
| 2020-08-14 | Status: Live/Pending |
| 2020-08-14 | Transaction Date |
| 2021-08-03 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  H. Lundbeck A/S |
| Entity Statement | A/S |
| Address | Ottiliavej 9 DK-2500 VALBY DK |
| Legal Entity Type | |
| Legal Entity State | DK |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceuticals and medical preparations and substances; vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, PSP, restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, headaches, pain, alcoholism and dependency; preparations, substances, reagents and agents for diagnostic and medical purposes |
| GS0051 | Pharmaceuticals and medical preparations and substances for use in the prevention, management and treatment of headaches, migraines, pain, and neurological disorders and conditions; Vaccines; Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; Pharmaceutical preparations and substances acting on the central nervous system; Central nervous system stimulants; Pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; Pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, PSP, restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, headaches, pain, alcoholism and dependency; Preparations, substances, reagents and agents for diagnostic and medical purposes, namely, for use in the prevention, management and treatment of headaches, migraines, pain, and neurological disorders and conditions |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2020-08-06 | 1 REPR M: |
| LIMITATION FROM ORIGINAL APPLICATION ENTERED | 2020-08-13 | 2 LIMI I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-08-14 | 3 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2020-08-14 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2020-08-17 | 5 CNRT R:Renewal |
| APPLICATION FILING RECEIPT MAILED | 2020-08-18 | 6 MAFR O:Outgoing Correspondence |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2020-08-18 | 7 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2020-09-23 | 8 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2020-09-23 | 9 RFCS P: |
| REFUSAL PROCESSED BY IB | 2020-10-11 | 10 RFNT P: |
| CHANGE OF OWNER RECEIVED FROM IB | 2020-11-09 | 11 DCPN M: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-11-25 | 12 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2021-02-25 | 13 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2021-02-26 | 14 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2021-02-26 | 15 TEME I:Incoming Correspondence |
| SUSPENSION LETTER WRITTEN | 2021-03-15 | 16 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2021-03-15 | 17 GNSL S: |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2021-03-15 | 18 GNS3 O:Outgoing Correspondence |
| TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2021-03-24 | 19 ERSI I:Incoming Correspondence |
| ASSIGNED TO LIE | 2021-03-25 | 20 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2021-03-26 | 21 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2021-03-26 | 22 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-04-12 | 23 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-04-28 | 24 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2021-04-28 | 25 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2021-04-28 | 26 OPNS P: |
| NOTIFICATION PROCESSED BY IB | 2021-05-17 | 27 GPNX P: |
| PUBLISHED FOR OPPOSITION | 2021-05-18 | 28 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-05-18 | 29 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2021-08-03 | 30 R.PR A:Allowance for Publication |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2021-11-03 | 31 FICR P: |
| FINAL DISPOSITION PROCESSED | 2022-01-07 | 32 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2022-01-07 | 33 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2022-02-20 | 34 FINO P: |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 ZYEPTI 87890415 not registered Live/Pending |
Alder BioPharmaceuticals, Inc. 2018-04-24 |
 ZYEPTI 79291195 not registered Live/Pending |
H. Lundbeck A/S 2020-02-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 